ARMCX3 Antibody

What is the molecular structure of ARMCX3 and how does this influence antibody epitope selection?

ARMCX3 (Armadillo Repeat Containing, X-Linked 3) is a 379 amino acid protein containing three armadillo (ARM) repeat domains and a DUF634 domain (domain of unknown function, amino acids 100-363). The protein features an N-terminal transmembrane domain (amino acids 7-25) and three armadillo domains (ARM1: amino acids 110-151, ARM2: amino acids 155-192, and ARM3: amino acids 234-272) .

When selecting antibodies, researchers should consider:

• Target region specificity: Several commercial antibodies target different amino acid regions, including AA 251-300, AA 291-340, and AA 299-325

• Domain-specific epitopes: Antibodies targeting the armadillo repeat domains versus the transmembrane region will yield different experimental outcomes

• Conservation across species: Epitopes with high sequence homology across species (e.g., human ARMCX3 shows 100% identity with chimpanzee, mouse, rat, and several other mammals in certain regions)

The choice of epitope has significant methodological implications, particularly when studying protein-protein interactions or when membrane association is relevant to the research question.

What are the key experimental applications for ARMCX3 antibodies and their validated performance criteria?

ARMCX3 antibodies have been validated for multiple experimental applications with specific performance criteria:

Critical validation parameters include:

• Specificity verification through knockout/knockdown controls

• Cross-reactivity testing with other armadillo repeat proteins

• Batch-to-batch consistency assessment

• Application-specific optimization (fixation methods for IHC/IF, buffer conditions for WB/IP)

How does species cross-reactivity impact experimental design when using ARMCX3 antibodies?

Species cross-reactivity is a critical consideration for researchers designing experiments with ARMCX3 antibodies:

• Sequence conservation: ARMCX3 shows high sequence homology across mammals, with certain epitopes (AA 251-300) showing 100% identity across human, mouse, rat, cow, pig, rabbit, horse, and bat

• Validated reactivity: Commercial antibodies have documented reactivity to specific species, with many showing confirmed reactivity to human and mouse samples

• Cross-species applications: When working with non-standard research models, sequence alignment analysis should be performed to predict reactivity

• Species-specific isoforms: Some antibodies may recognize species-specific ARMCX3 isoforms or post-translational modifications

For translational studies, researchers should:

• Select antibodies validated across multiple species when comparing rodent models to human samples

• Consider custom antibody development for exotic or non-validated species

• Perform preliminary validation experiments when extending to new species models

• Account for potential differential expression patterns between species

What are the optimized protocols for detecting ARMCX3 in Western blot experiments?

Based on published methodologies and validated antibody protocols, the following optimized Western blot procedure is recommended for ARMCX3 detection:

Sample Preparation:

• For cellular samples: Lyse cells directly in SDS sample buffer supplemented with protease inhibitors

• For tissue samples: Homogenize in RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, protease inhibitor mixture)

• Include 1 mM DTT to preserve protein structure

• Use 40 μg protein per lane for optimal detection

Electrophoresis and Transfer:

• Use 8% SDS-PAGE gels for optimal resolution of the 40-43 kDa ARMCX3 protein

• Transfer to PVDF membranes using standard protocols

Detection:

• Block membranes with 5% non-fat milk in TBST

• Incubate with primary antibody at 1:500-1:1000 dilution overnight at 4°C

• Use HRP-conjugated secondary antibodies at 1:8000 dilution

• Develop using ECL and expose for 30 seconds initially, adjusting as needed

Critical Controls:

• Include positive control samples (brain tissue exhibits high ARMCX3 expression)

• Include cell lines with known ARMCX3 expression (A172, K562)

• Consider using ARMCX3 knockout/knockdown samples as negative controls

How should researchers approach immunohistochemical detection of ARMCX3 in different tissue types?

Immunohistochemical detection of ARMCX3 requires tissue-specific optimization:

Fixation and Processing:

• For paraffin-embedded tissues: Standard formalin fixation works well for most tissues

• Antigen retrieval: Two validated approaches:

  • TE buffer pH 9.0 (preferred method)

  • Citrate buffer pH 6.0 (alternative method)

• For frozen sections: 4% PFA fixation with Triton X-100 permeabilization

Antibody Application:

• Primary antibody dilution ranges from 1:50-1:500 depending on tissue type and antibody

• Incubation times: 1-2 hours at room temperature or overnight at 4°C

• For fluorescence applications: Use Triton X-100 permeabilization to enhance mitochondrial detection

Tissue-Specific Considerations:

• Neural tissues: High endogenous expression facilitates detection

• Liver tissue: Expression levels vary with nutritional status

• Cancer tissues: Expression may be altered (e.g., thyroid cancer shows detectable levels)

• Embryonic tissues: Expression patterns change during development

Data Interpretation:

• Subcellular localization: ARMCX3 shows mitochondrial outer membrane localization

• Cell-type specificity: Expression varies across cell types within tissues

• Quantification approaches: Consider digital pathology tools for expression level analysis

What validation strategies are essential before using ARMCX3 antibodies in critical experiments?

Comprehensive validation of ARMCX3 antibodies is crucial for generating reliable research data:

Primary Validation Methods:

• Western blot confirmation of specificity:

  • Verify single band at the expected molecular weight (40-43 kDa)

  • Test multiple cell/tissue types for expression pattern confirmation

  • Compare results with transcript-level data (qPCR or RNA-seq)

• Genetic validation approaches:

  • ARMCX3 knockout/knockdown controls (using CRISPR-Cas9 or siRNA)

  • Overexpression controls to confirm signal increase

  • Compare multiple antibodies targeting different epitopes

• Cross-reactivity assessment:

  • Test in species where reactivity is predicted but not confirmed

  • Evaluate potential cross-reactivity with other armadillo repeat proteins

Application-Specific Validation:

• For co-immunoprecipitation: Validate protein interactions using reciprocal IP approaches

• For IHC/IF: Confirm staining patterns with multiple antibodies and correlate with transcript data

• For quantitative applications: Establish standard curves and linear detection ranges

Documentation Requirements:

• Record complete antibody information: catalog number, lot number, clonality, host

• Document all validation experiments with positive and negative controls

• Maintain validation records for publication requirements and reproducibility

How can ARMCX3 antibodies be employed to study its interaction with Sox10 and impact on transcriptional regulation?

ARMCX3 has been identified as a Sox10-interacting protein that enhances Sox10-mediated transcriptional activation. Researchers investigating this interaction should consider:

Co-immunoprecipitation Strategy:

• Reciprocal co-IP approach:

  • IP with anti-ARMCX3 antibody and blot for Sox10

  • IP with anti-Sox10 antibody and blot for ARMCX3

• Use of endogenous proteins in relevant cell types (e.g., OBL21 cells that express Sox10 endogenously)

• Preclearing of lysates with appropriate control IgG to reduce non-specific binding

Domain Mapping Experiments:

• Using deletion constructs of both proteins to identify interaction domains:

  • N-terminal 100 amino acids of Sox10 interact with ARMCX3

  • Multiple deletion constructs of ARMCX3 should be tested to map Sox10-binding regions

• Transfection of tagged constructs for mapping experiments (e.g., Myc-tagged ARMCX3)

Transcriptional Activation Assays:

• Reporter gene assays using promoters regulated by Sox10 (e.g., neuronal acetylcholine receptor subunit genes)

• Co-transfection of ARMCX3 and Sox10 expression vectors to assess cooperative effects

• ChIP assays to evaluate recruitment of ARMCX3 to Sox10 binding sites

Subcellular Localization Studies:

• Immunofluorescence to determine co-localization patterns

• Subcellular fractionation followed by Western blotting

• Analysis of mitochondrial-nuclear shuttling mechanisms

What methodological approaches can elucidate ARMCX3's role in hepatic metabolism and tumorigenesis?

Research has shown that ARMCX3 plays a significant role in hepatic metabolism and tumorigenesis, with ARMCX3 deficiency protecting against high-fat diet (HFD)-induced metabolic insults and hepatic tumorigenesis . Methodological approaches include:

Genetic Manipulation Models:

• Conditional knockout systems:

  • Tamoxifen-inducible UBC-Cre/ERT2 recombinase crossed with ARMCX3 floxed mice

  • Liver-specific promoters for targeted ARMCX3 deletion

• Overexpression models to assess gain-of-function effects

Metabolic Phenotyping:

• Assessment of glucose homeostasis:

  • Glucose tolerance tests

  • Insulin sensitivity assays

• Liver function analysis:

  • Measurement of plasma markers (ALT, AST, ALP, LDH)

  • Histological evaluation of hepatic steatosis

• Diet manipulation studies:

  • Comparison of low-fat diet (LFD) versus high-fat diet (HFD)

  • Nutritional challenge experiments to assess metabolic adaptability

Tumorigenesis Models:

• Diethylnitrosamine (DEN)-induced hepatic carcinogenesis:

  • Administration at 25 mg/kg to young mice

  • Evaluation of tumor development at defined time points

• Tumor characterization:

  • Quantification of tumor number, size, and maximum tumor size

  • Histopathological assessment

  • Molecular profiling of tumors

Expression Analysis:

• Western blot analysis of ARMCX3 protein levels under different nutritional conditions

• Correlation with metabolic parameters

• Comparative expression analysis between normal and tumor tissues

How can researchers investigate ARMCX3's role in neural development and differentiation?

ARMCX3 has been implicated in neural development, with overexpression reducing progenitor proliferation and promoting neural differentiation . Advanced methodological approaches include:

In Vivo Neural Development Models:

• Chick neural tube electroporation:

  • Targeted expression of ARMCX3 in neural progenitors using pCIG vectors

  • Analysis of proliferation and differentiation markers at defined time points

• Mouse embryonic brain development:

  • In utero electroporation for spatiotemporal control of expression

  • Lineage tracing experiments to follow cell fate decisions

Proliferation and Differentiation Assays:

• Cell cycle analysis:

  • BrdU incorporation for S-phase labeling

  • PH3 immunostaining for M-phase identification

• Neuronal differentiation assessment:

  • HuC/D expression as marker for differentiating neurons

  • Sox2 expression for neural progenitor identification

  • Tuj-1 (β-III tubulin) for neuronal lineage detection

Quantitative Analysis Approaches:

• Cell counting strategies:

  • Percentage of double-labeled cells (GFP/Sox2 or GFP/HuC/D)

  • Standardized area measurements of differentiation zones

• Statistical analysis:

  • Comparison of experimental versus control sides in neural tube

  • Time-course analysis of differentiation progression

Mechanistic Studies:

• Investigation of signaling pathways affected by ARMCX3:

  • WNT signaling, which negatively regulates ARMCX3 degradation

  • PKC pathway, which promotes ARMCX3 protein degradation

• Analysis of mitochondrial dynamics in developing neurons

What are common technical challenges when using ARMCX3 antibodies and their solutions?

Researchers frequently encounter several technical challenges when working with ARMCX3 antibodies:

Challenge: Weak or Absent Signal in Western Blot
Solutions:

• Sample preparation optimization:

  • Include protease inhibitors to prevent degradation

  • Use fresh samples or properly stored frozen samples

  • Consider subcellular fractionation to enrich for mitochondrial fraction

• Protocol adjustments:

  • Increase antibody concentration (try 1:500 instead of 1:1000)

  • Extend primary antibody incubation time to overnight at 4°C

  • Try alternative blocking agents (BSA instead of milk)

• Antibody selection:

  • Test antibodies targeting different epitopes (N-terminal vs. C-terminal)

  • Consider tissue/species-specific antibody recommendations

Challenge: Non-specific Bands or Background
Solutions:

• Increase stringency:

  • Additional washing steps with higher concentration of Tween-20

  • More stringent blocking (5% BSA or milk for longer periods)

  • Lower antibody concentration with longer incubation

• Antibody validation:

  • Test specificity using knockout/knockdown controls

  • Pre-adsorb antibody with immunizing peptide if available

• Sample quality:

  • Use freshly prepared samples to reduce degradation products

  • Ensure complete protein denaturation for WB applications

Challenge: Inconsistent Results Between Experiments
Solutions:

• Standardize protocols:

  • Document detailed protocols including temperatures, incubation times

  • Use the same lot number of antibody when possible

  • Maintain consistent sample preparation methods

• Include appropriate controls:

  • Positive control samples with known ARMCX3 expression

  • Loading controls for normalization

  • Internal standards for quantitative comparisons

How should researchers interpret contradictory results between different ARMCX3 antibodies?

When faced with contradictory results between different ARMCX3 antibodies, researchers should implement a systematic approach to reconcile the discrepancies:

Analytical Framework:

• Epitope mapping analysis:

  • Compare the target regions of each antibody (AA 251-300, AA 291-340, etc.)

  • Consider whether differences reflect isoform specificity or post-translational modifications

• Validation hierarchy establishment:

  • Prioritize results from antibodies validated with genetic controls

  • Consider species-specific optimization history

  • Evaluate publication record and independent validation

Experimental Reconciliation:

• Side-by-side comparison:

  • Test multiple antibodies simultaneously under identical conditions

  • Include positive and negative controls for each antibody

• Orthogonal validation:

  • Confirm protein expression with transcript analysis (qPCR, RNA-seq)

  • Use alternative detection methods (mass spectrometry)

• Functional validation:

  • Correlate antibody detection with known biological functions

  • Test interaction partners or subcellular localization patterns

Documentation and Reporting:

• Transparent reporting of discrepancies in publications

• Detailed methods sections specifying exact antibody information

• Inclusion of supplementary data showing results with multiple antibodies

• Discussion of potential biological explanations for differences

What controls are essential when using ARMCX3 antibodies to study protein-protein interactions?

When investigating ARMCX3 protein interactions, particularly with Sox10 or mitochondrial proteins, several critical controls are necessary:

Essential Controls for Co-Immunoprecipitation:

• Input controls:

  • Analysis of starting material to confirm presence of both proteins

  • Quantitative assessment of protein levels for comparison

• Negative controls:

  • IgG control from the same species as the IP antibody

  • Lysates from cells lacking one interaction partner

  • Competition with immunizing peptide when available

• Reciprocal IP verification:

  • IP with anti-ARMCX3 and blot for partner protein

  • IP with anti-partner protein and blot for ARMCX3

Controls for Protein Interaction Domains:

• Deletion construct controls:

  • Systematic testing of domain deletions in both proteins

  • Point mutations in key residues of interaction domains

• Direct binding assessment:

  • In vitro binding assays with purified proteins/domains

  • Yeast two-hybrid controls with empty vectors

Subcellular Localization Controls:

• Organelle markers:

  • Mitochondrial markers to confirm localization

  • Nuclear markers for transcription factor interactions

• Fractionation controls:

  • Marker proteins for different subcellular compartments

  • Quality control for fraction purity

Functional Interaction Controls:

• Transcriptional activity assays:

  • Reporter gene controls with mutated binding sites

  • Dose-response relationships in co-transfection experiments

• Mitochondrial function assays:

  • Transport dynamics in presence/absence of interaction partners

  • Functional readouts correlated with interaction status

How is ARMCX3 implicated in mitochondrial dynamics and neurological disorders?

Recent research has revealed ARMCX3's significant role in mitochondrial biology and potential implications for neurological disorders:

Mitochondrial Transport Regulation:

• ARMCX3 regulates mitochondrial aggregation and transport in axons of living neurons

• It links mitochondria to the TRAK2-kinesin motor complex through interactions with Miro and TRAK2

• This function is critical for proper distribution of mitochondria in neurons with high energy demands

Regulatory Mechanisms:

• Post-translational regulation:

  • ARMCX3 protein degradation is promoted by Protein Kinase C (PKC)

  • WNT1 signaling negatively regulates ARMCX3 degradation

  • This dynamic regulation enables responsive control of mitochondrial distribution

Neurodegenerative Disease Connections:

• ARMCX3 has been linked to Alzheimer's disease and other cognitive disorders

• Potential mechanisms include:

  • Disrupted mitochondrial transport leading to energy deficits at synapses

  • Altered transcriptional regulation through Sox10 interactions affecting neural maintenance

  • Impaired mitochondrial quality control in neurons

Emerging Research Approaches:

• Patient-derived models:

  • iPSC-derived neurons from neurodegenerative disease patients

  • Analysis of ARMCX3 expression, localization, and function

• Advanced imaging techniques:

  • Live-cell imaging of mitochondrial dynamics

  • Super-resolution microscopy of ARMCX3-mitochondria interactions

• Therapeutic targeting strategies:

  • Modulation of ARMCX3 levels or activity

  • Targeting ARMCX3-dependent mitochondrial transport mechanisms

What recent findings connect ARMCX3 to metabolic regulation and cancer biology?

Emerging research has established important connections between ARMCX3, metabolic regulation, and cancer biology:

Metabolic Regulation:

• ARMCX3 expression in liver is strongly modulated by nutritional status

• ARMCX3 knockout in mice:

  • Protects against high-fat diet (HFD)-induced metabolic insults

  • Improves glucose homeostasis

  • Reduces non-alcoholic fatty liver disease (NAFLD) development

• Liver function indicators show reduced hepatocellular injury in ARMCX3-KO mice on HFD

Cancer Biology Implications:

• Tumor suppressor activity:

  • ARMCX3 deficiency protects against diethylnitrosamine (DEN)-induced liver tumorigenesis

  • This protection is particularly pronounced under metabolic stress conditions (HFD)

• Clinical correlations:

  • ARMCX3 expression is altered in various cancer types

  • The name itself (ARM protein lost in epithelial cancers on chromosome X 3) suggests altered expression in epithelial cancers

Research Frontiers:

• Mechanistic investigations:

  • Elucidation of ARMCX3's role in metabolic signaling pathways

  • Identification of ARMCX3-regulated genes in metabolic tissues

• Translational applications:

  • ARMCX3 as a potential biomarker for metabolic disease susceptibility

  • Therapeutic targeting in metabolic dysfunction-associated cancers

• Integration with other biological processes:

  • Connection between ARMCX3's mitochondrial functions and metabolic regulation

  • Investigation of tissue-specific roles in metabolism versus neural development

How can researchers effectively use ARMCX3 antibodies to bridge molecular mechanisms with phenotypic outcomes?

Bridging molecular mechanisms with phenotypic outcomes requires sophisticated experimental approaches:

Multi-level Analysis Strategy:

• Integrated tissue-specific expression profiling:

  • Compare ARMCX3 expression patterns across tissues using validated antibodies

  • Correlate with physiological or pathological phenotypes

  • Track expression changes during development or disease progression

• Subcellular resolution studies:

  • Use high-resolution microscopy with ARMCX3 antibodies for precise localization

  • Combine with organelle markers (particularly mitochondrial)

  • Analyze dynamics in response to physiological stimuli or stress conditions

• Protein interaction networks:

  • Employ ARMCX3 antibodies for immunoprecipitation-mass spectrometry (IP-MS)

  • Characterize tissue-specific or condition-specific interaction partners

  • Map interaction changes during phenotypic transitions

Translational Research Applications:

• Human tissue studies:

  • Compare ARMCX3 expression in normal versus pathological human samples

  • Correlate with clinical parameters and outcomes

  • Develop tissue microarray approaches for high-throughput analysis

• Animal model validation:

  • Verify molecular mechanisms identified in vitro within in vivo contexts

  • Connect ARMCX3 manipulation with physiological outcomes

  • Use conditional approaches for temporal control of ARMCX3 function

• Cross-disciplinary integration:

  • Combine antibody-based detection with genomic and transcriptomic analyses

  • Correlate protein-level findings with metabolomic or lipidomic data

  • Develop computational models integrating multi-omics datasets